DNA X, Inc.
SONM· Nasdaq
SONMDNA X, Inc.
Filed Aug 12, 2020 · 10-Q · 43 days after period end · 0001564590-20-039717
| Metric | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|
| Revenue | $21.06M | $43.75M | $31.45M |
| Net Income | -$7.10M | -$6.08M | -$123.00K |
| EPS Diluted | -$0.22 | -$0.31 | -$3.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
DNA X, Inc. · CIK 1178697 · Engraved from SEC EDGAR
ended Jun 30, 2020 · filed Aug 12, 2020 · 43 d after period end
